Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity

International Journal of Immunopharmacology

Volumn 20, Issue 11, 1998, Pages 595-614

  Liang, Jinsheng ^a   Melican, David ^a   Cafro, Lauren ^a   Palace, Gerard ^a   Fisette, Leslie ^a   Armstrong, Robert ^a   Patchen, Myra L ^a  

^a Alpha Beta Technology Inc   (United States)

Author keywords

Antibiotic resistance; Betafectin( ); Immunomodulation; Infection; PGG Glucan; Rats; S aureus; Surgery

Indexed keywords

AMPICILLIN; BETAFECTIN; GLUCAN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SAMPLING; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALE; MONOCYTE; MORTALITY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS;

ABSORPTION; AMPICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BETA-GLUCANS; BIOLOGICAL AVAILABILITY; CYTOKINES; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; GLUCANS; HALF-LIFE; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PENICILLINS; RATS; RATS, WISTAR; RESPIRATORY BURST; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0032477308     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00007-1     Document Type: Article

References (73)

1. Adams D. S., Pero S. C., Mackin W. M., Auron P. E., Wakshull E. Abstr. 10:1953;1338.
2. Adams D. S., Pero S. C., Petro B., Nathans R., Mackin W. M., Wakshull E. J. Leukocyte Biol. 62:1997;865-873.
3. Amura C. R., Fontan P. A., Sanjuan N., Nociari M. M., Buzzola F. R., Sordelle D. O. APMIS. 103:1995;447-459.
4. Aviles A., Guzman R., Garcia E. L., Talavera A., Diaz-Maqueo J. C. Anticancer Drugs. 7:1996;392-397.
5. Babineau T. J., Hackford A., Kenler A., Bistrian B., Forse R. A., Fairchild P. G., Keroack M., Caushaj P., Benotti P. Arch. Surg. 129:1994;1204-1210.
6. Babineau T. K. J., Marcello P., Swails W., Kenler A., Bistrian B., Forse R. A. Ann. Surg. 220:1994;601-609.
7. Bleicher P., Mackin W. J. Biotechnol. Healthcare. 2:1995;207-222.
8. Bogwald J., Johnson E., Seljelid R. Scand. J. Immunol. 15:1982;297-304.
9. Brunke-Reese D., Mackin W. M. Abstr. 8:1994;216.
10. Cisneros R. L., Gibson III F. C., Tzianabos A. O. Infect. Immun. 64:1996;2201-2205.
11. Cook J. A., Holbrook T. W., Dougherty W. J. Infect. Immun. 37:1982;1261-1269.
12. Czop J. K., Austen K. F. J. Immunol. 135:1985;3388-3393.
13. Dinarello C. A. Eur. Cytokine Netw. 5:1994;517-531.
14. Dupont, E., and Walker, C, (Eds.), (1993). Molecular-cellular mechanisms of immunomodulatory drugs. Franklin Book Company, Inc., Elkins Park, PA.
15. Farrar M. A., Schreiber R. D. Ann. Rev. Immunol. 11:1993;571-611.
16. Fudenberg, H. H., Whitten, H. D., and Ambrogi, F. (Eds.), (1984). Immunomodulation: new frontiers and advances. Plenum Press, New York, NY.
17. Gibaldi, M., and Perrier, D., (Ed.) (1982). Drugs and the pharmaceutical sciences: pharmacokinetics. Marcel Dekker, Inc., New York, NY.
18. Gibson III F. C., Tzianabos A. O., Onderdonk A. B. Infect. Immun. 64:1996;1065-1069.
19. Gold H. S., Moellering R. C. Drug Ther. 335:1996;1445-1453.
20. Goldman R. Exp. Cell Res. 174:1988;481-490.
21. Goren M. B. Am. Rev. Respir. Dis. 125:1982;50.
22. Holyoake T. L. Blood Rev. 10:1996;189-200.
23. Ijzermans J. N. M., Marquet R. L. Immunobiol. 179:1989;456-473.
24. Jamas S., Easson D. D., Ostroff G. International Patent Publication Number WO. 94:1994;04163.
25. Kilgore K. S., Imlay M. M., Szaflarski J. D., Silverstein F. S., Malani A. N., Evans V. M., Warren J. S. Lab. Invest. 76:1997;191-201.
26. Kimura A., Sherwood R. L., Goldstein E. J. Reticuloendothel. Soc. 34:1983;1-11.
27. Kulicke W. M., Lettau A. I., Thielking H. Carbohydrate Res. 297:1997;135-143.
28. Lagrange P. H., Fourgeaud M. Int. J. Exp. Clin. Chemother. 4:1991;48-55.
29. Mackin W., Brunke-Reese D., Gu Y., Crotty C., Fisette L. Abstr. 94:1994;1994.
30. Mackin W., Brunke-Reese D., Gu Y., Crotty C., Fisette L. FASEB J. 8:1994;488.
31. Mackin W., Brunke-Reese D., Crotty C., Cafro L., Daunais M., Cabrera J., Fisette L., Bleicher P. FASEB J. 9:1995;521.
32. Meropol N. J., Petrelli N. J., Lipman B. J., Rodriguez-Bigas M., Hicks W., Douglass H. O., Smith J. L., Rasey M., Blumenson L. E., Vaickus L. Am. J. Surg. 172:1996;299-302.
33. Michalek M., Melican D., Brunke-Reese D., Langevin, Lemerise K., Galbraith W., Patchen M., Mackin W. J. Leukoc. Biol. 64:1998;337-344.
34. Muller A., Rice P. J., Ensley H. E., Coogan P. S., Kalbfleisch J. H., Kelley J. L., Love E. J., Ortera C. A., Hu T., Browder I. W., Williams D. L. J. Immunol. 156:1996;3418-3425.
35. Murray H. W. Intensive Care Med. 456:1996;461.
36. Nelson S. Clin. Infect. Dis. 197:1994;204.
37. Nemunaitis J. Crit. Rev. Oncol. Hematol. 14:1993;153-171.
38. Neu H. C. Sci. 257:1992;1064-1073.
39. Onderdonk A. B., Cisneros R. L., Hinkson P., Ostroff G. R. Infect. Immun. 60:1992;1642-1647.
40. Ostroff G. R., Jamas S., Wakshull E., Easson Jr. D. D., Oldham F., Marcello P., Bistrian B., Babineau T. J. Abstr. 93:1993;1993.
41. Patchen M. L., Liang J., Vaudrain T., Martin T., Melican D., Zhong S., Stewart M., Quesenberry P. J. Stem Cells. 16:1998;208-217.
42. Pero S. C., Wakshull E., Mackin W. M., Auron P. E., Adams D. S. FASEB J. 10:1952;1338.
43. Poutsiaka D. D., Mengozzi M., Vannier E., Sinha B., Dinarello C. A. Blood. 82:1993;3695-3700.
44. Pretus H. A., Ensley H. E., McNamee R. B., Jones E. L., Browder I. W., Williams D. L. J. Pharmacol. Exp. Ther. 257:1991;500-510.
45. Rasmussen L. T., Seljelid R. Scand. J. Immunol. 32:1990;321-331.
46. Rasmussen L. T., Fandrem J., Seljelid R. Scand. J. Immunol. 32:1990;333-340.
47. Rasmussen L. T., Seljelid R. J. Cell Biochem. 46:1991;60-68.
48. Reynolds J. A., Kastello M. D., Harrington D. G., Crabbs C. L., Peters C. J., Jemski J. V., Scott G. H., Di Luzio N. R. Infect. Immun. 30:1980;51-57.
49. Roilides E., Walsh T. J., Pizzo P. A., Rubin M. J. Infect. Dis. 163:1991;579-583.
50. Seljelid R., Bogwald J., Landwall A. Exp. Cell Res. 131:1981;121-126.
51. Service R. F. Sci. 270:1995;724-727.
52. Serrou, B., and Rosenfeld, C. (Ed.) (1982). New immunomodulating agents and biological response modifiers. Elsevier Science Publishing Company, Amsterdam, The Netherlands.
53. Shargel, L., and Yu, A. B. C. (Eds.), (1985). Applied biopharmaceutics and pharmacokinetics. Appleton-Century-Croft, New York, NY.
54. Sherwood E. R., Williams D. L., McNamee R. B., Jones E. L., Drowder I. W., DiLuzio N. R. Int. J. Immunopharmac. 9:1987;261-267.
55. Stashenko P., Wang C. Y., Riley E., Wu Y., Ostroff G., Niederman R. J. Dent. Res. 74:1995;323-330.
56. Tanaka S., Akitagawa J., Takahashi S., Shibata Y., Tsumuraya Y., Hashimoto Y. Carbohydrate Res. 218:1991;167-174.
57. Thorton B. P., Vetvicka V., Pitman M., Goldman R. C., Ross G. D. J. Immunol. 156:1996;1235-1246.
58. Tomasz A. New Engl. J. Med. 330:1994;1247-1251.
59. Tzianabos A. O., Cisneros R. L. Sci. 797:1996;285-287.
60. Tzianabos, A. O., Cisneros, R. L., and Kasper, D. L. (1998). Protection against mortality and abscess formation with intraabdominal sepsis by two polysaccharide immunomodulators. J. Clin. Invest. (In Press).
61. Vaara M. Sci. 274:1996;939-940.
62. Wakshull E., Lindermuth J., Zimmerman J. FASEB J. 10:1954;1338.
63. Wakshull, E., Brunke-Reese, D., Lindermuth, J., Fisette, L., Nathans, R., Crowley, J., Tufts, J., Zimmerman, J., Mackin, W., and Adams, D. (1998). PGG-Glucan, a soluble β-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: evidence for a uniqe β-glucan receptor. J. Immunopharmacology (submitted).
64. Washburn W. K., Otsu I., Gottschalk R., Monaco A. P. J. Surg. Res. 62:1996;179-183.
65. Williams D. L., Cook J. A., Hoffman E. O., DiLuzio N. R. J. Reticuloendothel. Soc. 23:1978;479-490.
66. Williams D. L., DiLuzio N. R. Sci. 208:1980;67.
67. Williams D. L., Browder I. W., DiLuzio N. R. Surg. 93:1983;448-454.
68. Williams D. L., Mueller A., Browder W. Clin. Immunother. 5:1996;392-399.
69. Williams J. D., Topley N., Alobaidi H. M. Immunol. 58:1986;117-124.
70. Wingard, L. B. Jr., Brody, T. M., Larner, J. J., and Schwartz, A. (Eds.), (1991). Human pharmacology: molecular to clinical. Mosby-Year Book, Inc., St. Louis, MO.
71. Wooles W. R., DiLuzio N. R. Sci. 142:1963;1078-1080.
72. Yamaguchi, H. (Ed.), (1993). Immunomodulatory drugs. N.Y. Acad. Sci., New York, NY.
73. Yamamura, Y., and Kotani, S. (Eds.), (1982). Immunomodulation by microbial products and related synthetic compounds. Elsevier Science Publishing Company, Amsterdam, The Netherlands.